

Both HCPs and pharmaceutical companies in the MEA regions have started recognizing the value of digital engagement for better reach. It has been found that 54% of HCPs now are willing to consider hybrid engagement model with pharmaceutical companies, 26% of HCPs prefer a virtual interaction over face-to-face interaction and 70% HCPs in MEA region are now interested to shift to newer ways of communication with pharmaceutical companies.
Read more about this in our latest white paper.